tradingkey.logo
tradingkey.logo

Pfizer raises annual profit forecast

ReutersAug 5, 2025 10:48 AM

- U.S. drugmaker Pfizer PFE.N raised its full-year profit forecast on Tuesday, boosted by robust demand for its heart disease drug, Vyndaqel, and some older treatments.

The drugmaker now expects to earn $2.90 to $3.10 per share on an adjusted basis in 2025, compared with its previous expectations of $2.80 to $3.00 per share.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI